688399 硕世生物
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额19,425145,925(113,144)1,964,878985,523
投资活动产生之现金流量净额(455,140)(873,013)462,348(717,888)(748,635)
筹资活动产生之现金流量净额(78,574)(94,756)55,259(667,426)(234,003)
汇率变动对现金及现金等价物的影响(1,449)850(1,266)757(1,535)
现金及现金等价物净增加/(减少)(515,738)(820,994)403,197580,3221,350
期初现金及现金等价物余额810,0081,631,0021,227,805647,483646,133
期末现金及现金等价物余额294,270810,0081,631,0021,227,805647,483